PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)
Clinical trial NCT02269813 · COMPLETED
Trial details
- NCT number
- NCT02269813
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-03-31
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.